2020-09-24 Comments Off on Anti-Influenza Drug Avigan® Tablet Meets Primary Endpoint in Phase III Clinical Trial in Japan for COVID-19 Patients Anti-Influenza Drug Avigan® Tablet Meets Primary Endpoint in Phase III Clinical Trial in Japan for COVID-19 Patients TOKYO — September 23, 2020 FUJIFILM Toyama Chemical Co., Ltd.